Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-10-08

Clinical Trial Update: Glucose Control Using 1,5-AG Testing [NA]

View source ↗

Summary

A completed clinical trial evaluating glucose control using 1,5-anhydroglucitol (1,5-AG) testing for diabetes management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Qure Healthcare, LLC | Conditions: Diabetes | NA | Status: COMPLETED | Results posted: 2020-10-08